3374-27-R-RFIN-00006

Closed State & local contract opportunity Posted

Solicitation number
3150007008
State
Mississippi
Responses due

Opportunity facts

Point of contact

Opportunity details come from ms.gov. Updated .

About this opportunity

The Mississippi Department of Mental Health has issued a notice of proposed sole source purchase for FDA-cleared Clozapine Test Kits, with a notice publication date of September 16, 2026 and a 15-calendar-day objection window closing September 30, 2026. This is a sole source acquisition, not a competitive solicitation.

The procurement covers FDA-cleared test kits for therapeutic drug monitoring of Clozapine, an antipsychotic medication requiring regular laboratory monitoring for patient safety within the state's mental health system. The sole source determination reflects the department's finding that the selected vendor's product is the only suitable option meeting the department's technical and clinical requirements.

Interested parties may submit written objections to the sole source justification within 15 calendar days of notice publication. Objections must be directed to the Mississippi Department of Mental Health's procurement office and must include specific documentation demonstrating the objecting party's capability to supply equivalent FDA-cleared products. The source does not identify the incumbent or named sole source vendor, estimated contract value, contract term, or place of performance.

Opportunity text

Sole Source Notice for FDA-cleared Clozapine Test Kits

Files

File Type Posted
NOTICE OF PROPOSED SOLE SOURCE PURCHASE 926-494.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Similar opportunities
  • Ask GovTribe AI about this opportunity